Suchergebnisse - "Frisell, Thomas"

PubPharm (12)

1

Malignancy outcomes in patients with rheumatoid arthritis treated with abatacept and other disease-modifying antirheumatic drugs : Results from a 10-year international post-marketing study

enthalten in: Seminars in arthritis and rheumatism | 2024

von Simon, T. | Suissa, S. | Boers, M. | +10

2

Are JAKis more effective among elderly patients with RA, smokers and those with higher cardiovascular risk? A comparative effectiveness study of b/tsDMARDs in Sweden

enthalten in: RMD open | 2023

von Bower, H. | Frisell, T. | di Giuseppe, D. | +8

3

Comparative cardiovascular safety with janus kinase inhibitors and biological disease-modifying antirheumatic drugs as used in clinical practice : an observational cohort study from Sweden in patients with rheumatoid arthritis

enthalten in: RMD open | 2023

von Bower, H. | Frisell, T. | di Giuseppe, D. | +2

4

Cancer risks with JAKi and biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis or psoriatic arthritis : a national real-world cohort study

enthalten in: Annals of the rheumatic diseases | 2023

von Huss, V. | Bower, H. | Hellgren, K. | +16

CommentIn: Ann Intern Med. 2023 Jul;176(7):JC83. - PMID 37399557

5

Safety of biological and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis as used in clinical practice : results from the ARTIS programme

enthalten in: Annals of the rheumatic diseases | 2023

von Frisell, T. | Bower, H. | Morin, M. | +21

6

Venous thromboembolism with JAK inhibitors and other immune-modulatory drugs : a Swedish comparative safety study among patients with rheumatoid arthritis

enthalten in: Annals of the rheumatic diseases | 2023

von Molander, V. | Bower, H. | Frisell, T. | +18

7

How do we use biologics in rheumatoid arthritis patients with a history of malignancy? An assessment of treatment patterns using Scandinavian registers

enthalten in: RMD open | 2020

von Chatzidionysiou, K. | Delcoigne, B. | Frisell, T. | +12

8

Gastrointestinal perforations in patients with rheumatoid arthritis treated with biological disease-modifying antirheumatic drugs in Sweden : a nationwide cohort study

enthalten in: RMD open | 2020

von Barbulescu, A. | Delcoigne, B. | Askling, J. | +1

9

Can rheumatoid arthritis (RA) registries provide contextual safety data for modern RA clinical trials? The case for mortality and cardiovascular disease

enthalten in: Annals of the rheumatic diseases | 2016

von Michaud, K. | Berglind, N. | Franzén, S. | +17

10

How comparable are rates of malignancies in patients with rheumatoid arthritis across the world? A comparison of cancer rates, and means to optimise their comparability, in five RA registries

enthalten in: Annals of the rheumatic diseases | 2016

von Askling, J. | Berglind, N. | Franzen, S. | +17